Fluid therapy in cardiac surgery. An update

被引:1
|
作者
Boix, E. [1 ]
Vicente, R. [2 ]
Perez-Artacho, J. [1 ]
机构
[1] Hosp Vinalopo, Serv Anestesiol Reanimac & Tratamiento Dolor, Alicante, Spain
[2] Hosp Univ Politecn La Fe, Serv Anestesiol Reanimac & Tratamiento Dolo, Unidad Reanimac, Valencia, Spain
来源
关键词
Fluid therapy; Cardiac surgery; Cardiac output; Hemodynamic monitoring; Echocardiography;
D O I
10.1016/j.redar.2013.01.006
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
The anesthetist has 2 major tools for optimizing haemodynamics in cardiac surgery: Vasoactive drugs and the intravascular volume. It is necessary to identify which patients would benefit from one or the other therapies for a suitable response to treatment. Hemodynamic monitoring with the different existing parameters (pressure, volumetric static, volumetric functional and echocardiography) allows the management of these patients to be optimized. In this article a review is presented on the most recent and relevant publications, and the different toots available to control the management of the fluid therapy in this context, and to suggest a few guidelines for the haemodynamics monitoring of patients submitted to cardiac surgery. A systematic search has been made in PubMed, limiting the results to the publications over the last five years up to February 2012. (C) 2012 Sociedad Espanola de Anestesiologia, Reanimation y Terapeutica del Dolor. Published by Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码:21 / 27
页数:7
相关论文
共 50 条
  • [31] Choice of Fluid Therapy and Bleeding Risk After Cardiac Surgery
    Reddy, Sumeet
    McGuinness, Shay
    Parke, Rachael
    Young, Paul
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2016, 30 (04) : 1094 - 1103
  • [32] Dental status of patients undergoing cardiac surgery.
    Qvarnstrom, M
    Meurman, JH
    Nuutinen, P
    Rehnberg, S
    Laakso, M
    Kotilainen, R
    Alhava, E
    JOURNAL OF DENTAL RESEARCH, 1997, 76 (05) : 1129 - 1129
  • [33] Operative risk factors of polyvalvular cardiac surgery.
    Nouar, MEA
    Lounes, K
    Laouer, H
    Barrache, FZ
    Djenas, M
    Mehyaoui, R
    Zerhouni, Z
    Amrane, MO
    ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 2001, 94 (01): : 51 - 56
  • [34] Cardiac troponin T in beating heart surgery.
    Hooper, J
    Kemp, M
    Donovan, J
    CLINICAL CHEMISTRY, 2002, 48 (06) : A87 - A87
  • [35] HLA Antibody Increase Associated with Cardiac Surgery.
    Warner, P.
    Aldea, G.
    Gallagher, M.
    Nelson, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 326 - 326
  • [36] Outcomes of lung transplantation combined with cardiac surgery.
    Chang, ASY
    Gonzalez-Stawinski, GV
    Najam, F
    Mehta, A
    Pettersson, G
    Murthy, S
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 346 - 346
  • [37] Alteration of sinus variability after cardiac surgery.
    Brembilla-Perrot, B
    Jacquemin, L
    Danchin, N
    Mathieu, P
    Villemot, JP
    Haouzi, A
    Schwalm, F
    ANNALES DE CARDIOLOGIE ET D ANGEIOLOGIE, 1998, 47 (03): : 149 - 154
  • [38] Microemboli are not associated with delirium after cardiac surgery.
    Wigginton, J. B.
    Rudolph, J. L.
    Babikian, V. I.
    Pochay, V. E.
    Khuri, S. F.
    Marcantonio, E. R.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2007, 55 (04) : S218 - S218
  • [39] Cardiac specificity of troponins in major vascular surgery.
    BenAyed, S
    Godet, G
    Foglietti, MJ
    Bernard, M
    CLINICAL CHEMISTRY, 1997, 43 : 5 - 5
  • [40] Coagulation management in cardiac surgery. Current strategies
    Albes, J. M.
    ZEITSCHRIFT FUR HERZ THORAX UND GEFASSCHIRURGIE, 2014, 28 (02): : 87 - 95